A. Anand

发表

The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.

S. Chu, J. Vinjé, J. Sherchand, 2016, Vaccine.

Unexpectedly high HIV prevalence among female sex workers in Bangkok, Thailand in a respondent-driven sampling survey

S. Whitehead, L. Johnston, U. Siangphoe, 2013, International journal of STD & AIDS.

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.

M. Pallansch, M. Yunus, M. Oberste, 2021, Vaccine.

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.

M. Pallansch, M. Yunus, S. Luby, 2015, Vaccine.

Poliovirus vaccination options for achieving eradication and securing the endgame.

M. Pallansch, R. Sutter, S. Wassilak, 2013, Current opinion in virology.

South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.

J. Liyanage, P. O'Connor, A. Anand, 2011, The Journal of infectious diseases.

Sequential inactivated and oral poliovirus vaccine schedules: a balancing act.

K. Zaman, A. Anand, 2020, The Lancet. Infectious diseases.

Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.

U. Parashar, D. Emperador, B. Lopman, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Complex task to estimate immune responses to various poliovirus vaccines and vaccination schedules.

K. Zaman, A. Anand, 2019, The Lancet. Infectious diseases.

Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.

Eric Stevens, W. Weldon, Dexiang Chen, 2018, Biologicals : journal of the International Association of Biological Standardization.

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018

G. Tallis, A. Anand, Zaixing Zhang, 2019, MMWR. Morbidity and mortality weekly report.

Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.

R. Sutter, Harish Verma, S. Bahl, 2016, MMWR. Morbidity and mortality weekly report.

Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2018-2019.

N. Gumede, O. Diop, J. Iber, 2020, MMWR. Morbidity and mortality weekly report.

Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi

A. Abdul-Quader, R. Bunnell, K. Kamoto, 2009, AIDS.

Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data

Abhijeet Anand, John Fricks, Emily Simons, 2012, The Lancet.

Site factors may be more important than participant factors in explaining HIV test acceptance in the prevention of mother‐to‐child HIV transmission programme in Kenya, 2005

K. Sabin, W. Mutsotso, O. Bolu, 2009, Tropical medicine & international health : TM & IH.

Stability of the age distribution of measles cases over time during outbreaks in Bangladesh, 2004-2006.

K. Wannemuehler, J. Goodson, P. O'Connor, 2011, The Journal of infectious diseases.

Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015

K. Russell, L. Hampton, S. Chai, 2017, The Journal of infectious diseases.

Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.

U. Parashar, M. Cortese, T. Hyde, 2022, The Lancet. Infectious diseases.

Utility of antenatal HIV surveillance data to evaluate prevention of mother-to-child HIV transmission programs in resource-limited settings.

W. Hladik, K. Sabin, O. Bolu, 2007, American journal of obstetrics and gynecology.

Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial

K. Wannemuehler, M. Pallansch, M. Yunus, 2019, The Lancet.

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference

Fatema Khaton, F. Qadri, S. Luby, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Building on success--potential to improve coverage of multiple health interventions through integrated delivery with routine childhood vaccination.

E. Luman, P. O'Connor, A. Anand, 2012, The Journal of infectious diseases.

Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys.

M. Pallansch, S. Wassilak, H. Gary, 2014, The Journal of infectious diseases.

Cluster Survey Evaluation of a Measles Vaccination Campaign in Jharkhand, India, 2012

K. Wannemuehler, Heather M. Scobie, S. Bahl, 2015, PloS one.

Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2016–2017

Abhijeet Anand, Smita Chavan, Jaume Jorba, 2018, MMWR. Morbidity and mortality weekly report.

Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal

E. Burnett, S. Dixit, R. Rajbhandari, 2017, The Journal of infectious diseases.

Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.

M. Pallansch, M. Yunus, W. Weldon, 2018, The Lancet. Infectious diseases.

Impact of COVID-19 Pandemic on Global Poliovirus Surveillance

O. Diop, Jamal A. Ahmed, C. Chauvin, 2021, MMWR. Morbidity and mortality weekly report.

Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)

D. Zehrung, C. Jarrahian, A. Anand, 2017, Vaccine.

Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000–2010

K. Wannemuehler, S. Chu, M. Pallansch, 2013, Epidemiology and Infection.

Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2019–2020

O. Diop, J. Jorba, Jamal A. Ahmed, 2021, MMWR. Morbidity and mortality weekly report.

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.

M. Pallansch, J. Vertefeuille, Bernardo A. Mainou, 2023, The Lancet. Infectious diseases.

Bridging Populations—Sexual Risk Behaviors and HIV Prevalence in Clients and Partners of Female Sex Workers, Bangkok, Thailand 2007

S. Whitehead, K. Sabin, C. Manopaiboon, 2011, Journal of Urban Health.

Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.

M. Pallansch, N. Molodecky, R. Sutter, 2017, Vaccine.

Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial.

S. Chu, M. Pallansch, Mahmudur Rahman, 2015, The Lancet. Infectious diseases.

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India

A. Anand, M. Pereira, V. Inamdar, 2011, The Indian journal of medical research.

Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2016–2017

O. Diop, J. Jorba, Jamal A. Ahmed, 2018, MMWR. Morbidity and mortality weekly report.